Accelerating commercialization of wireless power supplies for EVs and active pharmaceutical ingredients with an eye on the ...

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced ...

Omeros Corporation (NASDAQ: OMER) today announced that it will host an industry session at the 52nd Annual Meeting of the ...

In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the first immunotherapy combination approved for adult and pediatric patients 12 ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired ...

Macau SAR, China regulator grants approval for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in patients with BCG-unresponsive ...

Groundbreaking power products designed to solve power challenges in low-profile, high-energy density applicationsSAN ANTONIO- ...

"You cannot claim to follow science while bypassing the scientific process," said Duane Boise, CEO of MMJ International ...

SIOUX FALLS, SD / ACCESS Newswire / March 20, 2026 / States across the country are preparing to deploy $50 billion in federal funding through the Rural Health Transformation Program (RHT) to modernize ...

New interim data from the KONFIDENT-KID trial evaluating sebetralstat in children aged 2-11 accepted for late-breaking oral ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its ...

ALEXANDRIA, VA / ACCESS Newswire / March 20, 2026 / The American Society of Consultant Pharmacists (ASCP) today issued the ...